Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 5.118\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) COc1ccc(-c2cc(C3CCN(Cc4ccc([N+](=O)[O-])cc4)CC3)[nH]n2)cc1
(b) O=C(COC(=O)c1ccc(S(=O)(=O)N2CCCC2)cc1)Nc1ccc(Cl)cc1
(c) Cc1cccc(CN2CCC(C(=O)Nc3ccc(-n4nc(C)cc4C)cc3)CC2)n1
(d) CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCN1CCOCC1
(e) O=C(O)/C(=C\c1cccc(F)c1)c1ccc(S(=O)(=O)N2CCCC2)s1
Answer: d. CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCN1CCOCC1
CC(Oc1ccc(Cl)cc1Cl)C(=O)NCCN1CCOCC1
2-(2,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)propanamide